Core Viewpoint - Shenwan Hongyuan has faced significant challenges in its IPO underwriting business, leading to a drastic decline in its performance and reputation due to regulatory issues and high project withdrawal rates [2][11][15]. Group 1: IPO Performance and Regulatory Issues - Shenwan Hongyuan's IPO underwriting income dropped by 97% in 2024 compared to 2023, with only one successful IPO project remaining [2][10]. - The company received seven penalties in 2024, a stark contrast to zero penalties in 2023, indicating a deterioration in compliance and operational standards [2][11]. - The IPO withdrawal rate reached 90% in 2024, significantly higher than the 33.3% rate in 2023, raising concerns about the firm's ability to maintain its A-class rating in the upcoming evaluations [11][15]. Group 2: Specific Cases of Regulatory Failures - Shenwan Hongyuan was criticized for its role in the IPO application of Guohong Tools, which was found to have falsified information regarding its R&D personnel and expenditures [3][4]. - The company failed to adequately verify the qualifications of R&D personnel, leading to a misrepresentation of the company's compliance with the Sci-Tech Innovation Board's requirements [4][5]. - Regulatory bodies have issued warnings and penalties against Shenwan Hongyuan for its inadequate due diligence and oversight in various projects, including the handling of the Hainuoer and Guohong Tools IPOs [16][17]. Group 3: Future Outlook - With only three IPO projects in total, including one from the Beijing Stock Exchange, Shenwan Hongyuan's competitive position in the IPO market is under scrutiny [9][10]. - The company's ability to recover its A-class rating in the 2025 evaluation is uncertain, given the current trajectory of its IPO performance and regulatory challenges [11][18].

Core Viewpoint - The article highlights the strict enforcement of the "responsibility upon application" principle for IPOs in China, emphasizing accountability for companies and intermediaries involved in the IPO process, particularly in cases of significant violations [1][2]. Company Summary - Guohong Tools System (Wuxi) Co., Ltd. was established in 2004 and specializes in the research, production, and sales of ultra-high precision CNC tools and integrated circuit packaging wedge-shaped cutting tools [1]. - The company submitted its IPO application to the Shanghai Stock Exchange for listing on the Sci-Tech Innovation Board in June 2023 but decided to withdraw the application in April 2024, less than a year later [1]. Regulatory Actions - The Shanghai Stock Exchange issued four disciplinary actions against Guohong Tools for violations related to its IPO application, resulting in a one-year rejection of its listing application and criticism directed at its sponsor, Shenwan Hongyuan, as well as its auditing and legal advisory firms [1][2]. - Shenwan Hongyuan was found to have inadequately fulfilled its sponsorship responsibilities, including insufficient verification of R&D personnel and investment accuracy, governance deficiencies, and accounts receivable risks [2][3]. Financial Discrepancies - Guohong Tools reported inflated R&D expenditures, with total reported investments of 12.76 million, 15.33 million, and 18.65 million yuan for the years 2020 to 2022, respectively, which accounted for 5.35% of total revenue over three years [2]. - The company misclassified 15 R&D personnel who were actually in non-R&D roles and inaccurately reported R&D expenditures, overstating them by 7.28 million yuan [3].